Loading
Latest filing published 26 Sept 2024 for 道氏技术, €142k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
张翼 (chief executive) discloses dealings in 2 companies, chiefly 天坛生物 and 道氏技术. Over a trading history stretching from 8 September 2023 to 26 September 2024, the count stands at 2 filings.
Purchases make up the whole of the open-market record (2 purchases, €213k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2024 to date brings 1 purchase and no sales.
On 26 September 2024 came the latest disclosure, an open-market purchase for €142k in 道氏技术. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.